We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3][4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & Fr...

Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide. Why invest in GSK? David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.

We unite science, technology and talent to get ahead of disease together. Ahead Together. Innovation to prevent and treat disease is at the heart of everything we do. We aim to positively impact the health of 2.5 billion people by the end of the decade.

1 天前 · The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc (“GSK” or “the Company”) (NYSE: GSK) for violations of ...

View recent trades and share price information for GSK plc (GSK) ORD GBP0.3125.

Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

See the company profile for GSK plc (GSK) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their...

5 天之前 · GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.